BR100 Increased By (0.11%)
BR30 Decreased By (-0.26%)
KSE100 Increased By (0.12%)
KSE30 Increased By (0.09%)
AGHA 7.81 Increased By ▲ 0.06 (0.77%)
BECO 5.21 Increased By ▲ 0.02 (0.39%)
BML 57.50 Decreased By ▼ -1.16 (-1.98%)
BOP 34.03 Increased By ▲ 0.34 (1.01%)
CNERGY 9.96 Decreased By ▼ -0.65 (-6.13%)
CSIL 5.31 Increased By ▲ 0.01 (0.19%)
FCCL 54.70 Increased By ▲ 0.96 (1.79%)
FFL 16.69 Increased By ▲ 0.23 (1.4%)
FNEL 1.23 Increased By ▲ 0.01 (0.82%)
KEL 7.40 Increased By ▲ 0.12 (1.65%)
KOSM 5.77 Increased By ▲ 0.13 (2.3%)
LOTCHEM 29.32 Decreased By ▼ -0.33 (-1.11%)
MLCF 94.36 Decreased By ▼ -2.00 (-2.08%)
NBP 203.05 Decreased By ▼ -0.48 (-0.24%)
NCPL 57.00 Increased By ▲ 0.15 (0.26%)
NPL 67.70 Increased By ▲ 0.39 (0.58%)
OGDC 315.84 Decreased By ▼ -2.38 (-0.75%)
PACE 10.64 Increased By ▲ 0.01 (0.09%)
PAEL 43.20 Increased By ▲ 1.43 (3.42%)
PIBTL 16.74 Decreased By ▼ -0.07 (-0.42%)
PPL 219.78 Decreased By ▼ -0.39 (-0.18%)
PRL 49.19 Increased By ▲ 0.14 (0.29%)
PTC 70.53 Increased By ▲ 0.52 (0.74%)
SSGC 28.25 Decreased By ▼ -0.89 (-3.05%)
TBL 9.86 Increased By ▲ 0.09 (0.92%)
TELE 8.79 Decreased By ▼ -0.03 (-0.34%)
TPL 18.24 Increased By ▲ 1.07 (6.23%)
TPLP 13.27 Increased By ▲ 0.76 (6.08%)
TREET 22.72 Increased By ▲ 0.13 (0.58%)
TRG 60.14 Decreased By ▼ -0.08 (-0.13%)
Pakistan

Anyone 65 and above can register for COVID-19 vaccine from next week: Asad Umar

  • The vaccination of those who register in this category will start in March," Asad Umar tweeted.
  • On February 3, Pakistan began its vaccination drive with the Chinese Sinopharm vaccine.
Published Updated

Minister for Planning and Development Asad Umar announced on Wednesday that registration for coronavirus vaccination for those 65 years and above will be opening next week.

In his tweet, the minister said that vaccination of those who register in this category will start in March. On February 3, Pakistan began its vaccination drive which aims to inoculate over one million healthcare workers with the Chinese Sinopharm vaccine. The Drug Regulatory Authority of Pakistan (DRAP) had approved the Chinese state-owned firm's vaccine for emergency use last month.

DRAP has so far approved Sinopharm's vaccine, Russia's Sputnik V vaccine, and the vaccine developed by Oxford University-AstraZeneca. Meanwhile, COVAX has said that 17 million doses of the Astra­Zeneca vaccine would be provided to Pakistan in the first half of 2021. Around 7million will be available by March.

Since the outbreak of the novel virus last year, Pakistan has confirmed 557,591 cases and 12,128 deaths. Currently, there are 30,512 active COVID-19 cases in the country. Meanwhile, 514,951 people have also recovered from the virus.

Comments

Comments are closed for this article.